Sort
11,323 grants matching “glioblastoma”
Nanoparticles to Track T Cell Immunotherapy Using Magnetic Particle Imaging
$472,110Carlos M Rinaldi-Ramos · University Of Florida · R01 · FY2022 · EB
Mechanisms of Biguanide Sensitivity in GBM
$472,108Biplab Dasgupta · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · NS
Targeting Neoantigens in Glioblastoma
$471,961Gavin Peter Dunn · Washington University · R01 · FY2020 · NS
MYC-dependent loss of splicing fidelity in Glioblastoma multiforme
$471,895Patrick Paddison · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA
Targeting AVIL in Glioblastoma
$471,746Hui Li · University Of Virginia · R01 · FY2024 · CA
PREcision Disease preventIon via somatiC muTagenesis enumeratION (PREDICTION)
$471,680Jason H Bielas · Fred Hutchinson Cancer Research Center · U01 · FY2018 · ES
Precision disease prevention via somatic mutagenesis enumeration (PREDICTION)
$471,680Jason H Bielas · Fred Hutchinson Cancer Research Center · U01 · FY2019 · ES
Precision disease prevention via somatic mutagenesis enumeration (PREDICTION)
$471,680Eric C Holland · Fred Hutchinson Cancer Center · U01 · FY2022 · ES
Precision disease prevention via somatic mutagenesis enumeration (PREDICTION)
$471,680Jason H Bielas · Fred Hutchinson Cancer Research Center · U01 · FY2020 · ES
Targeting oncogenic dopamine receptor signaling in glioblastoma
$471,662Jeongwu Lee · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · CA
Targeting oncogenic dopamine receptor signaling in glioblastoma
$471,662Jeongwu Lee · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · CA
Retroviral Coded Functions
$471,252Maxine L Linial · Fred Hutchinson Cancer Research Center · R01 · FY2011 · CA
Mechanisms underlying BAI1/ADGRB1 negative regulation of glioblastoma mesenchymal transition and invasion.
$471,248Erwin G Van Meir · University Of Alabama At Birmingham · R01 · FY2023 · NS
Development of Clinical Strategies to Prevent GBM Recurrences After Radiotherapy
$471,083John Martin Brown · Stanford University · R01 · FY2014 · CA
Systemic Delivery of Targeted Bi-Compartmental Nanoparticles for Glioblastoma Therapeutics
$470,970Joerg Lahann · University Of Michigan At Ann Arbor · R01 · FY2025 · NS
Chromatin Modifications in GBM-Propagating Cells
$470,805John J Laterra · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2020 · NS
Project 2: Exploiting Labile Iron Pools for Improving NSCLC Therapy Using Pharmacological Ascorbate
$470,783Douglas Robert Spitz · University Of Iowa · P01 · FY2022 · CA
Project 1: Ionic Modulation of Chromatin in Cancer
$470,655Thomas V O'Halloran · Northwestern University At Chicago · U54 · FY2017 · CA
Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain Cancers
$470,637Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2018 · CA
Multiscale Resolution and Deep Network Approaches for Deconvolving Different Cell Types in Bulk Tumor using Single-cell Sequencing Data (scDEC)
$470,040Xiaobo Zhou · University Of Texas Hlth Sci Ctr Houston · R01 · FY2021 · CA
Targeting epigenetic machinery to overcome myeloid cell-mediated resistance to anti-PD-1 therapy in GBM
$469,956Sangeeta Goswami · University Of Tx Md Anderson Can Ctr · R37 · FY2023 · CA
Targeting epigenetic machinery to overcome myeloid cell-mediated resistance to anti-PD-1 therapy in GBM
$469,956Sangeeta Goswami · University Of Tx Md Anderson Can Ctr · R37 · FY2025 · CA
Cell-Surface Interactions in Pathogenesis
$469,913Kenneth Yamada · National Institute Of Dental & Craniofacial Research · ZIA · FY2018 · DE
AHR-mediated immunosuppression in glioblastoma
$469,890Francisco J. Quintana · Brigham And Women'S Hospital · R01 · FY2023 · ES
Clinical evaluation of IL13Ra2-targeted CAR T cell therapy in combination with nivolumab in patients with recurrent malignant glioma
$469,554Christine Brown · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA